corona
virus
mostli
zoonot
virus
human
corona
strain
usual
caus
mild
respiratori
gastrointestin
syndrom
rare
lead
sever
diseas
last
decad
two
import
corona
virus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
cross
anim
human
barrier
emerg
becom
major
human
pathogen
sarscov
merscov
caus
diseas
outbreak
signific
morbid
mortal
chang
understand
pathogen
potenti
coronavirus
although
merscov
first
recogn
human
respiratori
pathogen
saudi
arabia
merscov
antibodi
detect
dromedari
camel
store
sera
eastern
africa
earli
sinc
human
infect
report
countri
global
novemb
total
laboratoryconfirm
case
merscov
report
major
case
report
arabian
peninsula
case
either
origin
pass
though
saudi
arabia
saudi
arabia
south
korea
report
largest
number
case
outsid
middl
east
due
larg
outbreak
earli
result
return
south
korean
citizen
travel
arabian
peninsula
sinc
reduct
overal
report
case
saudi
arabia
case
report
outsid
arabian
peninsula
despit
drop
report
case
outbreak
continu
occur
saudi
arabia
neighbor
gulf
countri
laboratori
confirm
case
case
hospit
acquir
includ
health
care
worker
effect
prevent
therapeut
intervent
becom
avail
merscov
continu
major
public
health
challeng
econom
burden
affect
countri
world
search
pubm
embas
cochran
scopu
googl
scholar
use
follow
term
mer
merscov
middl
east
respiratori
syndrom
combin
prevent
infect
control
also
review
refer
articl
includ
studi
report
identifi
search
averag
incub
period
merscov
day
rang
day
report
clinic
diseas
spectrum
rang
complet
asymptomat
mild
diseas
sever
diseas
multiorgan
failur
symptomat
patient
symptom
present
may
includ
fever
chill
rigor
myalgia
malais
cough
short
breath
gastrointestin
symptom
diarrhea
vomit
abdomin
pain
may
present
part
upper
respiratori
syndrom
main
present
complain
pneumonia
common
present
sever
infect
occur
special
among
older
patient
comorbid
present
acut
respiratori
renal
failur
shock
crude
fatal
rate
averag
among
primari
case
among
secondari
case
predictor
poor
outcom
includ
age
year
male
gender
diabet
mellitu
chronic
lung
diseas
chronic
renal
diseas
low
albumin
level
progress
lymphocytopenia
use
steroid
continu
renal
replac
therapi
also
suggest
predictor
wors
outcom
merscov
infect
notic
infrequ
pediatr
popul
pediatr
patient
usual
asymptomat
present
mild
symptom
infect
frequent
acquir
household
contact
associ
low
morbid
mortal
percentag
asymptomat
case
primari
infect
variabl
precis
known
earlier
studi
estim
around
merscov
infect
may
asymptomat
recent
studi
suggest
may
asymptomat
differ
studi
set
popul
studi
method
screen
may
explain
variabl
use
serolog
test
underestim
diseas
burden
due
wane
antibodi
titer
time
asymptomat
case
report
detect
follow
aggress
contact
trace
prolong
viral
excret
respiratori
tract
week
document
special
patient
pneumonia
present
albeit
low
load
viru
secret
also
report
shorter
period
urin
stool
patient
mild
symptom
also
viral
shed
day
symptom
onset
merscov
envelop
singlestrand
rna
viru
famili
coronavirida
subfamili
coronavirina
four
describ
coronaviru
genera
alpha
beta
gamma
delta
beta
coronaviru
genera
includ
two
genet
relat
distinct
human
pathogen
zoonot
origin
b
lineag
sarscov
origin
c
lineag
merscov
bat
origin
c
lineag
divid
genet
sub
lineag
clade
includ
least
two
merscov
strain
potenti
exist
addit
clade
merscov
first
lineag
known
infect
human
merscov
genom
encod
protein
includ
four
structur
protein
e
n
surfac
spike
glycoprotein
protein
gain
attent
confer
receptor
specif
primari
target
humor
immun
respons
infect
current
key
focu
merscov
vaccin
antivir
therapeut
develop
effort
protein
consist
subunit
receptor
bind
domain
rbd
subunit
respons
cellular
receptor
bind
region
mediat
viru
fusion
entri
target
cell
srbd
contain
critic
neutral
domain
induc
potent
neutral
antibodi
srbd
specif
neutral
antibodi
titer
correl
protect
merscov
infect
dipeptidyl
also
known
adenosin
deaminas
complex
protein
cluster
differenti
protein
encod
gene
express
surfac
cell
type
includ
noncili
bronchial
cell
includ
endotheli
alveolar
epitheli
cell
type
ii
pneumocyt
macrophag
fibroblast
function
receptor
merscov
host
cell
surfac
util
receptorbind
domain
merscov
spike
primari
origin
human
camel
merscov
probabl
vesper
bat
southern
africa
first
transfer
bat
camel
like
occur
africa
recombin
event
lead
genet
diverg
origin
bat
viru
merscov
antibodi
detect
camel
sera
long
first
human
case
report
merscov
camel
caus
mild
symptom
trade
infect
camel
africa
like
introduc
viru
arabian
peninsula
dromedari
camel
eventu
camel
human
transmiss
first
recogn
merscov
infect
widespread
among
dromedari
camel
arabian
peninsula
abund
evid
link
dromedari
camel
human
infect
ident
genom
sequenc
merscov
camel
owner
symptomat
anim
ident
merscov
rna
fragment
detect
air
barn
report
viral
genom
sequenc
similar
infect
human
one
isol
camel
outbreak
site
mani
camel
virus
classifi
clade
correl
human
outbreak
high
seropreval
merscov
infect
among
camel
shepherd
slaughterhous
worker
although
dromedari
camel
confirm
intermedi
anim
host
merscov
infect
domest
livestock
like
sheep
goat
contact
merscov
infect
camel
may
risk
infect
livestock
role
human
transmiss
yet
clear
howev
exposur
camel
could
document
half
patient
primari
merscov
infect
high
merscov
seropreval
among
expos
camel
alway
consist
human
diseas
burden
directli
proport
potenti
exposur
camel
indic
although
cameltohuman
transmiss
occur
effici
occur
rel
uncommonli
independ
risk
factor
increas
risk
camel
human
transmiss
includ
direct
close
physic
contact
involv
anim
train
milk
camel
contact
camel
wast
poor
hand
hygien
anim
task
presenc
host
comorbid
infect
like
acquir
via
contact
camel
respiratori
droplet
saliva
camel
respiratori
organ
slaughter
consumpt
camel
product
milk
urin
undercook
camel
meat
nasal
swab
lung
tissu
posit
merscov
especi
among
anim
year
age
merscov
ad
unpasteur
camel
milk
store
remain
infecti
beyond
h
commun
transmiss
common
occur
sporad
exposur
infect
dromedari
camel
contact
symptomat
human
case
within
famili
caus
famili
cluster
travel
associ
infect
report
human
incub
viru
travel
associ
infect
howev
contribut
modestli
commun
transmiss
merscov
rare
caus
commun
acquir
pneumonia
new
human
case
repres
new
introduct
merscov
camel
zoonot
spillov
merscov
poorli
suit
sustain
humantohuman
transmiss
estim
primari
case
sustain
outbreak
amplif
via
poor
hygien
practic
individu
especi
around
camel
new
merscov
case
predominantli
restrict
arabian
peninsula
outbreak
outsid
region
gener
selflimit
populationbas
studi
show
low
overal
preval
merscov
gener
popul
rang
male
camelexpos
individu
higher
merscov
infect
rate
although
season
variat
found
studi
other
notic
increas
rate
april
june
true
commun
preval
howev
may
underestim
due
antibodi
wane
time
report
suggest
limit
humantohuman
transmiss
within
household
small
number
contact
becom
infect
report
famili
cluster
involv
contact
patient
rel
hospit
set
infect
anim
commun
truli
commun
primari
infect
transmiss
take
place
air
droplet
produc
cough
sneez
indirectli
close
contact
contamin
surfac
devic
transmiss
via
bodi
fluid
like
urin
stool
vomitu
also
theoret
possibl
becausemerscov
isol
secret
recent
evid
clearli
shown
merscov
transmiss
asymptomat
individu
occur
merscov
cultur
patient
mild
symptom
detect
day
asymptomat
contact
asymptomat
health
care
worker
detect
merscov
five
week
given
transmiss
asymptomat
individu
occur
sar
outbreak
may
also
possibl
merscov
factor
facilit
commun
transmiss
includ
lack
knowledg
transmiss
mechan
poor
gener
hygien
practic
exposur
camel
primari
merscov
human
case
also
like
occur
condit
rel
cold
dri
key
measur
prevent
commun
transmiss
diseas
control
camel
avoid
camel
contact
much
possibl
commun
awar
diseas
prudent
though
health
educ
health
care
facil
remain
vigil
especi
around
time
high
diseas
activ
diseas
control
camel
requir
effect
camel
vaccin
current
licens
camel
vaccin
howev
viral
vector
vaccin
two
mva
modifi
vaccinia
viru
ankara
two
chimpanze
adenoviru
oxford
univers
mer
vaccin
incorpor
dna
sequenc
encod
merscov
surfac
protein
test
anim
model
mva
vaccin
dromedari
camel
led
signific
reduct
merscov
viru
viral
rna
transcript
detect
level
serum
neutral
merscovspecif
antibodi
mvavector
vaccin
neutral
antibodi
although
camel
vaccin
manag
reduc
viral
shed
respons
seen
across
vaccin
anim
durat
protect
also
known
merscov
diseas
caus
mild
symptom
camel
accept
owner
vaccin
mild
diseas
may
futur
challeng
consid
widespread
preval
merscov
infect
camel
control
commun
transmiss
includ
avoid
close
contact
camel
camel
barn
area
camel
market
especi
high
risk
group
also
essenti
practic
good
hygien
around
camel
especi
symptomat
camel
high
diseas
activ
usual
occur
april
may
june
juli
period
new
camel
gener
becom
suscept
merscov
infect
declin
matern
protect
antibodi
individu
screen
merscov
test
posit
includ
asymptomat
mild
symptom
underli
comorbid
heart
diseas
renal
failur
immunecompromis
condit
sent
home
recoveri
patient
still
remain
risk
rapid
diseas
progress
need
monitor
first
week
ill
precaut
prevent
transmiss
household
detail
individu
box
includ
educ
mechan
merscov
transmiss
import
gener
hygien
especi
hand
cough
hygien
patient
adequ
separ
person
hous
separ
room
possibl
least
separ
bed
share
household
item
secret
like
bodi
fluid
sweat
saliva
sputum
vomitu
urin
potenti
sourc
transmiss
appropri
barrier
use
deal
secret
barrier
reus
absorb
materi
cotton
prefer
nonabsorpt
materi
household
item
share
person
item
laundri
wash
thoroughli
heat
easili
inactiv
merscov
surfac
counter
tabletop
doorknob
bathroom
fixtur
toilet
phone
keyboard
tablet
bedsid
tabl
disinfect
everi
day
use
epaapprov
household
disinfect
essenti
visitor
come
comorbid
close
contact
infect
person
share
space
home
good
air
flow
appropri
follow
healthcar
system
maintain
till
full
incub
period
laps
usual
day
longer
period
may
appropri
remain
symptomat
immunocompromis
patient
like
shed
viru
longer
durat
gener
public
health
perspect
increas
commun
awar
diseas
transmiss
mechan
import
public
knowledg
test
among
two
level
educ
sampl
saudi
arabia
univers
high
school
acknowledg
fever
cough
manifest
merscov
infect
minor
thought
camel
product
associ
higher
risk
infect
author
conclud
measur
aim
educ
improv
public
prevent
measur
use
tissu
sneez
cough
proper
tissu
dispos
need
anoth
studi
done
femal
univers
saudi
arabia
assess
awar
merscov
prevent
strategi
follow
outbreak
citi
respond
recogn
typic
symptom
merscov
knew
recommend
prevent
hygien
practic
overal
knowledg
score
awar
diseas
epidemiolog
sever
fatal
rate
treatment
low
result
highlight
import
inform
share
knowledg
defici
occur
import
key
measur
crucial
merscov
transmiss
knowledg
gap
expect
even
higher
among
less
educ
individu
given
individu
outbreak
link
hospit
human
human
transmiss
healthcar
set
appear
effici
transmiss
within
commun
healthcar
associ
outbreak
constitut
largest
number
laboratoryconfirm
merscov
case
infect
rate
merscov
healthcar
facil
fourfold
averag
estim
household
transmiss
rate
hospit
acquir
merscov
infect
experi
significantli
longer
hospit
stay
like
die
diseas
transmiss
occur
patient
health
care
worker
visitor
within
patient
among
healthcar
worker
within
facil
well
facil
episod
outbreak
hospit
hallmark
merscov
infect
main
sourc
new
case
report
risk
factor
transmiss
merscov
healthcar
set
studi
extens
merscov
rel
stabl
hospit
environ
facilit
transmiss
recover
surfac
h
rel
humid
least
h
humid
viru
also
recover
liquid
h
patient
room
environ
includ
bed
sheet
medic
equip
day
patient
merscov
pcr
turn
neg
unlik
sarscov
merscov
titer
sputum
sampl
infect
patient
high
within
first
day
symptom
make
transmiss
effici
earli
cours
diseas
nosocomi
outbreak
merscov
result
larg
explos
cluster
case
call
superspread
event
defin
abil
infect
patient
transmit
viru
other
fever
extens
chest
infiltr
high
viral
load
identifi
risk
factor
effici
spread
signific
risk
factor
hospit
transmiss
howev
delay
recognit
delay
initi
isol
use
proper
ppe
number
nonisol
inhospit
day
paramet
associ
superspread
event
even
delay
isol
patient
led
secondari
infect
earli
activ
quarantin
essenti
reduc
size
outbreak
inadequ
laps
infect
control
measur
inpati
outpati
set
observ
hospit
outbreak
breach
infect
control
measur
vari
howev
around
highrisk
aerosol
gener
procedur
high
risk
area
like
hemodialysi
respiratori
intens
care
unit
frequent
observ
overcrowd
also
signific
risk
factor
merscov
transmiss
outbreak
two
larg
merscov
outbreak
saudi
arabia
south
korea
crowd
emerg
room
hospit
ward
lack
proper
control
visitor
play
signific
role
increas
transmiss
box
airflow
ventil
also
implic
caus
effici
spread
within
hospit
although
merscov
known
spread
mainli
droplet
via
close
contact
merscov
air
droplet
travel
long
distanc
significantli
larger
condit
allow
like
presenc
extern
airflow
among
health
care
worker
nurs
commonli
affect
follow
physician
respiratori
therapist
infect
healthi
adult
healthcar
worker
mild
discov
contact
trace
infect
healthcar
worker
howev
significantli
amplifi
merscov
infect
outbreak
case
report
among
hospit
laundri
mainten
worker
one
case
mainten
housekeep
personnel
screen
major
outbreak
saudi
arabia
date
clear
evid
sustain
persontoperson
transmiss
report
inadequ
laps
infect
control
measur
inpati
outpati
set
observ
hospit
outbreak
common
breach
infect
control
measur
center
around
highrisk
aerosol
gener
procedur
high
risk
area
like
hemodialysi
respiratori
intens
care
unit
basic
principl
merscov
prevent
relay
establish
administr
environment
measur
ensur
earli
recognit
use
personnel
protect
equip
prevent
cross
transmiss
healthcar
facil
creat
polici
procedur
invest
heavili
infrastructur
infect
prevent
control
ensur
effici
implement
administr
measuresit
crucial
alloc
appropri
resourc
train
support
healthcar
personnel
well
establish
monitor
process
polici
sporad
natur
merscov
outbreak
mandat
continu
vigil
maintain
high
level
awar
across
year
environment
manag
essenti
domain
merscov
prevent
ensur
appropri
ventil
patient
alloc
environment
disinfect
along
effici
mechan
monitor
personnel
protect
equip
ppe
essenti
tool
break
transmiss
chain
healthcar
facil
provid
adequ
sustain
suppli
item
includ
gown
glove
highli
effici
mask
goggl
face
shield
demand
ppe
increas
dramat
suppli
remain
adequ
time
protocol
use
ppe
constant
train
audit
mandatori
especi
place
high
turnov
rate
employe
clinic
predictor
merscov
pneumonia
present
er
includ
overweight
diabet
mellitu
endstag
renal
diseas
respiratori
distress
admiss
normal
wbc
interstiti
infiltr
chest
x
ray
risk
predict
model
merscov
pneumonia
develop
incorpor
gender
contact
sick
patient
camel
diabet
pneumonia
sever
present
low
white
blood
cell
wbc
count
low
alanin
aminotransferas
alt
high
aspart
aminotransferas
ast
molecular
test
current
standard
method
diagnosi
merscov
infect
base
detect
viral
rna
clinic
sampl
realtim
reversetranscript
polymeras
chain
reaction
rrtpcr
assay
posit
rrtpcr
two
specif
genom
target
singl
posit
target
sequenc
second
target
upper
respiratori
sampl
nasopharyng
swab
lower
respiratori
specimen
need
obtain
lower
respiratori
sampl
better
yield
due
higher
viral
load
nasopharyng
oropharyng
specimen
accept
altern
patient
mild
symptom
deep
respiratori
sampl
practic
patient
initi
neg
upper
respiratori
sampl
subsequ
intub
would
requir
repeat
deep
respiratori
sampl
intub
multipl
sampl
may
need
especi
highli
suspect
case
diagnosi
rule
due
intermitt
shed
discontinu
isol
least
neg
fever
symptom
cough
sputum
product
dyspnea
longer
interv
symptom
onset
isol
diagnosi
pneumonia
pulmonari
infiltr
lung
zone
mechan
ventil
crp
mgdl
symptom
onset
neg
convers
day
median
primari
case
oppos
secondari
tertiari
chain
transmiss
nonisol
inhospit
day
non
isol
inhospit
day
day
hospit
emerg
room
visit
isol
patient
visitor
hcw
involv
care
frequent
preisol
pneumonia
diagnos
lower
cycl
threshold
upe
gene
patient
outcom
deceas
vs
recov
presenc
comorbid
signific
multivari
analysi
super
spread
suspect
case
laboratori
confirm
merscov
infect
sever
pneumonia
sever
score
point
sever
score
communityacquir
pneumonia
curb
ard
base
clinic
radiolog
evid
epidemiolog
link
requir
ii
unexplain
deterior
chronic
condit
patient
congest
heart
failur
chronic
kidney
diseas
hemodialysi
epidemiolog
link
requir
iii
acut
febril
ill
c
withwithout
respiratori
symptom
epidemiolog
link
requir
ivgastrointestin
symptom
diarrhea
vomit
leukopenia
thrombocytopenia
platelet
epidemiolog
link
requir
epidemiolog
link
exposur
confirm
case
merscov
infect
visit
healthcar
facil
merscov
patient
recent
within
week
identifiedtr
contact
dromedari
camel
consumpt
camel
product
eg
raw
meat
unpasteur
milk
urin
within
day
symptom
onset
sampl
h
apart
clinic
improv
need
serolog
also
use
confirm
diagnosi
requir
demonstr
seroconvers
sampl
taken
day
apart
screen
elisa
ifa
confirm
neutral
assay
health
care
facil
implement
effici
screen
process
point
entri
hospit
medic
care
area
especi
high
risk
area
like
emerg
hemodialysi
critic
care
respiratori
care
unit
prove
huge
challeng
sinc
data
efficaci
triag
screen
appli
saudi
ministri
health
moh
fail
prevent
outbreak
screen
alon
expect
sole
factor
prevent
outbreak
better
understand
spectrum
diseas
present
may
enhanc
screen
efficaci
monitor
complianc
screen
procedur
strict
vigil
especi
high
merscov
activ
prudent
absenc
effici
reliabl
costeffect
point
care
test
appli
hot
area
mention
optim
audit
screen
may
valuabl
compon
minim
outbreak
potenti
outbreak
corona
heavi
season
patient
screen
fever
symptom
respiratori
infect
use
screen
templat
triag
dedic
area
prompt
diagnost
work
isol
indic
screen
prove
effect
control
ongo
transmiss
outbreak
control
measur
one
saudi
hospit
implement
twostep
screen
process
creat
drive
emerg
entranc
initi
triag
patient
either
dedic
respiratori
unit
main
emerg
area
similarli
health
care
worker
hcw
work
critic
area
like
isol
ward
icu
hemodialysi
unit
visitor
area
also
screen
fever
respiratori
symptom
countri
ongo
risk
transmiss
dedic
respiratori
clinic
could
set
separ
quarantin
area
within
main
emerg
area
distinct
separ
physic
area
clear
pathway
patient
staff
follow
clinic
must
design
reduc
potenti
transmiss
exit
entri
unit
must
well
control
patient
wait
area
spaciou
well
ventil
space
patient
least
patient
room
singl
feasibl
neg
pressur
hepa
filter
especi
aerosol
gener
symptom
procedur
need
patient
respiratori
symptom
need
given
surgic
mask
reduc
aerosol
educ
materi
unit
util
increas
commun
awar
merscov
infect
proper
cough
etiquett
dedic
ward
critic
care
unit
need
alloc
admit
patient
emerg
room
admit
hospit
area
merscov
reliabl
exclud
care
observ
transfer
emerg
room
er
design
area
reduc
transmiss
may
includ
measur
contain
patient
secret
patient
admit
singl
room
feasibl
neg
pressur
critic
care
unit
ideal
singl
room
possibl
adequ
distanc
patient
observ
everi
person
enter
patient
room
use
design
ppe
equip
droplet
airborn
isol
proper
protocol
suspect
confirm
case
place
standard
contact
droplet
precaut
airborn
precaut
patient
requir
aerosolgener
medic
procedur
mechan
ventil
endotrach
intub
endotrach
aspir
due
well
document
prolong
merscov
shed
infect
control
precaut
appli
two
consecut
lower
respiratori
tract
sampl
sputum
tracheal
aspir
apart
becom
rna
neg
patient
becom
asymptomat
strict
infect
control
measur
observ
sampl
collect
includ
use
approv
collect
method
equip
transport
sampl
accord
appropri
protocol
sampl
prefer
collect
neg
pressur
room
especi
deep
respiratori
sampl
train
healthcar
profession
traffic
control
elimin
overcrowd
emerg
depart
clinic
area
essenti
reduc
er
time
restrict
visitor
er
educ
visitor
sitter
wear
mask
observ
basic
infect
control
measur
like
hand
hygien
provid
poster
educ
materi
creat
visitor
log
allow
person
laboratori
confirm
merscov
infect
irrespect
clinic
sign
symptom
probabl
case
febril
acut
respiratori
ill
clinic
radiolog
histopatholog
evid
pulmonari
parenchym
diseas
eg
pneumonia
acut
respiratori
distress
syndrom
direct
epidemiolog
link
laboratoryconfirm
merscov
case
test
merscov
unavail
neg
singl
inadequ
specimen
inconclus
ii
febril
acut
respiratori
ill
clinic
radiolog
histopatholog
evid
pulmonari
parenchym
diseas
eg
pneumonia
acut
respiratori
distress
syndrom
explain
fulli
etiolog
person
resid
travel
middl
east
countri
merscov
known
circul
dromedari
camel
human
infect
recent
occur
test
merscov
inconclus
iii
acut
febril
respiratori
ill
sever
direct
epidemiolog
link
confirm
merscov
case
test
merscov
inconclus
direct
epidemiolog
link
confirm
merscov
patient
may
includ
health
care
associ
exposur
includ
provid
direct
care
merscov
patient
work
health
care
worker
infect
merscov
visit
patient
stay
close
environ
individu
infect
merscov
ii
work
togeth
close
proxim
share
environ
individu
infect
merscov
iii
travel
togeth
individu
infect
merscov
kind
convey
iv
live
household
individu
infect
merscov
v
epidemiolog
link
may
occur
within
period
onset
ill
case
consider
rapid
identif
assess
contact
risk
level
measur
util
outbreak
saudi
arabia
south
korea
hcw
educ
train
infect
prevent
control
tool
emerg
infect
refresh
skill
regularli
although
hcw
seem
understand
import
infect
control
practic
like
hand
hygien
fail
properli
implement
protocoldriven
hand
hygien
applic
use
ppe
inconsist
among
hcw
even
though
merscov
identifi
sinc
outbreak
continu
occur
saudi
arabia
continu
involv
substanti
number
hcw
outbreak
vigil
observ
infect
control
practic
among
hcw
ensur
readi
prudent
earli
detect
isol
patient
expos
highrisk
contact
minim
patient
load
imper
control
outbreak
merscov
outbreak
set
earli
quarantin
expos
individu
follow
assess
monitor
contact
signific
oppos
quarantin
assess
close
contact
less
laborintens
timeconsum
like
shorten
delay
isol
merscov
patient
healthcar
set
outbreak
mani
individu
expos
identif
expos
individu
may
difficult
inde
patient
korea
outbreak
identifi
expos
individu
monitor
outbreak
healthcar
facil
especi
limit
infect
control
infrastructur
strain
even
total
paralyz
huge
increment
increas
cost
resourc
util
measur
need
place
elimin
cross
infect
may
includ
increas
manpow
budget
resourc
realloc
merscov
outbreak
saudi
arabia
implement
intensifi
goal
orient
educ
program
healthcar
provid
especi
work
critic
area
emphasi
rule
nurs
educ
impact
posit
cross
infect
staff
confid
environment
clean
crucial
housekeep
receiv
dedic
train
wear
ppe
time
clean
surfac
thoroughli
clean
disinfect
least
daili
frequent
need
use
eparegist
disinfect
clean
disinfect
surfac
around
patient
also
prudent
aerosol
gener
procedur
viru
hardi
invitro
data
shown
differ
concentr
povidon
iodin
suffici
kill
viru
although
total
number
merscov
case
report
rel
small
major
outbreak
south
korea
highlight
risk
travel
pose
countri
healthcar
system
travelassoci
merscov
case
report
least
countri
relat
travel
incub
merscov
travel
transmiss
airplan
document
date
saudi
arabia
host
two
larg
religi
mass
gather
annual
million
muslim
divers
ethnic
group
visit
though
limit
number
merscov
case
amongst
pilgrimag
travel
return
saudi
arabia
observ
relat
contact
larg
dromedari
camel
present
makkah
area
saudi
ministri
health
recommend
includ
elderli
peopl
year
age
chronic
diseas
eg
heart
diseas
kidney
diseas
respiratori
diseas
diabet
pilgrim
immun
defici
congenit
acquir
malign
termin
ill
pregnant
women
children
postpon
perform
hajj
umrah
safeti
also
prudent
peopl
come
hajj
umrah
avoid
contact
camel
employ
relat
migrat
common
reason
travel
middl
eastern
countri
host
larg
foreignborn
popul
migrant
worker
mani
busi
travel
visit
tropic
subtrop
area
travel
middl
east
travel
associ
merscov
case
includ
busi
travel
expatri
resid
middl
east
includ
healthcar
provid
case
among
travel
histori
contact
dromedari
camel
travel
countri
within
arabian
peninsula
especi
highrisk
group
like
diabet
immunosuppress
chronic
lung
diseas
preexist
renal
failur
advis
risk
travel
need
avoid
visit
farm
barn
area
market
environ
camel
present
addit
avoid
contact
camel
camel
slaughter
hous
drink
unpasteur
milk
gener
camel
milk
specif
consum
camel
raw
product
eat
food
may
contamin
anim
secret
product
unless
properli
wash
peel
cook
alway
vigil
person
hygien
measur
mandatori
around
camel
extrem
caution
avoid
sick
anim
sick
owner
vigil
hand
hygien
practic
travel
respiratori
symptom
stay
arabian
peninsula
countri
seek
medic
attent
alway
practic
cough
etiquett
cover
cough
sneez
dispos
tissu
maintain
distanc
wash
hand
postpon
return
travel
longer
symptomat
possibl
develop
respiratori
symptom
within
day
return
seek
medic
attent
provid
histori
recent
trip
type
exposur
anim
risk
merscov
infect
signific
public
health
concern
effici
commun
network
essenti
transpar
share
realtim
inform
help
gain
trust
increas
awar
readi
commun
healthcar
facil
battl
merscov
coordin
effort
minim
barrier
implement
appropri
effici
healthcar
strategi
control
merscov
infect
especi
heavili
affect
countri
reliabl
updat
sourc
inform
healthcar
provid
healthcar
institut
establish
nation
level
similar
reliabl
trustabl
sourc
merscov
infect
inform
also
establish
public
order
minim
panic
yet
increas
awar
although
internet
power
tool
spread
inform
method
dissemin
inform
respect
variabl
educ
level
access
inform
endus
develop
effect
safe
afford
longlast
human
vaccin
merscov
effici
costeffect
medic
countermeasur
block
anim
human
transmiss
prevent
infect
vaccin
target
high
risk
group
like
hcw
close
contact
dromedari
camel
vaccin
studi
initi
hinder
multipl
challeng
includ
absenc
econom
incent
sinc
merscov
infect
occur
sporad
human
mostli
contain
one
geograph
area
also
suitabl
anim
model
merscov
diseas
test
anoth
challeng
neutral
antibodi
titer
wane
rapidli
overtim
human
recov
merscov
infect
leav
uncertainti
durat
protect
coalit
epidem
prepared
innov
cepi
innov
partnership
public
privat
philanthrop
civil
organ
found
davo
develop
vaccin
stop
futur
epidem
develop
merscov
vaccin
set
prioriti
cepi
due
continu
threat
global
public
health
high
mortal
step
led
signific
expedit
perus
vaccin
develop
merscov
move
largescal
develop
begin
clinic
trial
multipl
candid
vaccin
differ
phase
trial
test
anim
human
clinic
trial
ongo
type
vaccin
platform
name
subunit
vaccin
dna
vaccin
viral
vector
vaccin
live
attenu
inactiv
vaccin
major
vaccin
develop
set
clinic
trial
base
viral
protein
fragment
key
vaccin
target
merscov
aim
stimul
host
immun
respons
immunogen
base
fulllength
protein
subunit
led
strong
antibodi
andor
cellular
immun
respons
mice
rabbit
nonhuman
primat
protect
reduc
sever
merscov
infect
anim
adjuv
merscov
spike
protein
subunit
vaccin
result
reduc
delay
viral
shed
upper
airway
dromedari
camel
although
lower
titer
serum
neutral
antibodi
observ
induct
robust
neutral
humor
immun
andor
cellular
immun
respons
vaccin
would
prevent
human
infect
anim
reduc
viral
shed
diminish
risk
zoonot
transmiss
vaccin
multipl
immunogen
epitop
ideal
viru
escap
phenomenon
hope
provid
crossprotect
futur
heterolog
strain
within
lineag
induc
harm
immun
respons
inherit
risk
vaccin
safeti
profil
potenti
immunopatholog
consequ
must
vigor
demonstr
clinic
trial
preclin
test
futur
merscov
vaccin
need
consid
heterolog
model
show
efficaci
safeti
previou
studi
sar
shown
differ
effect
young
old
anim
success
vaccin
balanc
achiev
protect
yet
caus
excess
immun
activ
one
report
suggest
ribavirin
lopinavirritonavir
day
high
risk
exposur
patient
sever
merscov
preisol
pneumonia
result
decreas
risk
infect
mild
advers
effect
observ
treatment
report
includ
patient
replic
confirm
effect
antibodybas
therapi
merscov
one
therapeut
intervent
extens
studi
current
antimerscov
antibodi
approv
human
use
yet
howev
human
anim
antibodi
investig
vaccin
develop
specif
target
protein
key
antibodi
neutral
human
monoclon
antibodi
investig
target
merscov
receptor
bind
domain
rbd
test
cell
cultur
anim
model
confer
variabl
level
protect
lung
viral
load
remind
high
mab
despit
symptom
control
target
epitop
target
receptor
bind
domain
also
use
includ
mab
antagonist
peptid
fusion
inhibitor
proteas
inhibitor
short
interf
rna
sirna
antimerscov
polyclon
immunoglobulin
produc
protein
nanoparticleimmun
transchromosom
tc
cattl
immun
middl
east
respiratori
syndrom
mer
coronaviru
vaccin
demonstr
safeti
toler
human
phase
trial
success
use
antibodi
treatment
merscov
infect
requir
combin
target
differ
neutral
epitop
function
region
merscov
protein
combin
antibodi
divers
target
mechan
action
avoid
gener
escap
mutant
viru
strain
improv
antivir
activ
diverg
viru
strain
human
antibodi
also
prefer
anim
origin
avoid
immun
reaction
merscov
primarili
zoonot
infect
first
recogn
human
pathogen
saudi
arabia
camel
known
anim
reservoir
merscov
anim
human
transmiss
occur
viral
infect
camel
reach
threshold
episod
human
transmiss
occur
camel
vaccin
ideal
way
block
camel
human
transmiss
least
significantli
reduc
transmiss
risk
commun
transmiss
effici
occur
main
factor
lead
sustain
merscov
infect
high
risk
courtier
healthcar
facil
transmiss
merscov
transmiss
healthcar
facil
mainli
result
lap
infect
control
measur
late
isol
suspect
case
although
current
human
vaccin
avail
signific
progress
made
success
vaccin
must
balanc
achiev
protect
yet
caus
excess
immun
activ
vaccin
antivir
therapeut
would
ideal
differ
mechan
action
avoid
gener
escap
mutant
viru
strain
improv
activ
diverg
viru
strain
prevent
measur
merscov
includ
diseas
control
camel
prevent
camel
human
transmiss
key
measur
prevent
commun
transmiss
includ
avoid
close
contact
camel
barn
area
camel
market
special
high
risk
group
monitor
diseas
activ
camel
good
hygien
practic
around
camel
merscov
poorli
suit
humantohuman
transmiss
primari
case
repres
anim
spillov
sustain
outsid
healthcar
facil
number
vaccin
candid
develop
yet
test
larg
scale
current
studi
suggest
candid
vaccin
develop
reduc
viral
shed
may
enough
prevent
human
transmiss
durat
protect
also
known
merscov
diseas
caus
mild
symptom
camel
accept
owner
vaccin
mild
diseas
may
n
e
futur
challeng
prevent
healthcar
facil
transmiss
main
amplifi
persist
outbreak
control
commun
transmiss
prevent
infect
healthcar
facil
essenti
sinc
healthcar
transmiss
effici
commun
transmiss
repres
individu
outbreak
inadequ
laps
infect
control
measur
inpati
outpati
sit
import
risk
factor
transmiss
late
identif
case
delay
isol
patient
far
prevent
strategi
adopt
effect
screen
prompt
diagnost
method
crowd
control
import
intervent
suspect
confirm
case
place
standard
contact
droplet
precaut
airborn
precaut
patient
requir
aerosolgener
medic
procedur
mechan
ventil
endotrach
intub
endotrach
aspir
due
well
document
prolong
merscov
shed
infect
control
precaut
appli
two
consecut
lower
respiratori
tract
sampl
sputum
tracheal
aspir
apart
becom
rna
neg
patient
becom
asymptomat
strict
infect
control
measur
observ
sampl
collect
includ
use
approv
collect
method
equip
transport
sampl
accord
appropri
protocol
sampl
prefer
collect
neg
pressur
room
especi
deep
respiratori
sampl
train
healthcar
profession
symptomat
individu
expos
merscov
requir
hospit
admiss
care
isol
home
wear
surgic
mask
observ
cough
etiquett
remain
restrict
activ
asymptomat
hcw
merscov
exposur
quarantin
remain
vigil
fever
develop
respiratori
symptom
keep
infect
control
offic
inform
test
weekli
would
return
work
two
respiratori
sampl
neg
paper
fund
author
relev
affili
financi
involv
organ
entiti
financi
interest
financi
conflict
subject
matter
materi
discuss
manuscript
includ
employ
consult
honoraria
stock
ownership
option
expert
testimoni
grant
patent
receiv
pend
royalti
